COVID and SARS News

• New Insights Into How Patient Factors and COVID-19 Infection Affect Antibody Responses in People With HIV

• Primary Series and Original Booster Provide Protection Against Omicron Infection

• New Omicron Subvariant BQ.1.1 Resistant to All Therapeutic Antibodies, Study Finds

• COVID-19 Vaccine Gives Substantial Protection Against Reinfection, Study Finds

• Global COVID-19 Infection Rates May Be Higher Than Previously Reported

• COVID-19 Vaccination Leads to Higher Antibody Levels Than Natural Infection in Both Pregnant People and Their Babies, Study Finds

• Moderna's COVID-19 Vaccine Safe and Effective for Young Children, Study Finds

• Study Finds High Prevalence of COVID-19 and Flu Co-Infections During 2021-2022 Flu Season

• Getting to the Heart of COVID-19 Vaccination and Its Cardiovascular Risks

• New Light on Key Differences in Immune Response to SARS-CoV-2 Vaccines
• New Insights on Antibody Responses to Omicron Variants

• Multistate Study Examines mRNA Vaccine Effectiveness for Immunocompromised Adults During Omicron BA.4 and BA.5 Predominance
• How Severe Is the SARS-CoV-2 Omicron BA.2 Subvariant Compared With Earlier Variants?

• Study Uncovers Mechanisms Necessary for SARS-CoV-2 Infection in Macrophages
• Intranasal COVID Vaccine That Works Against Variants in Animals

• Third COVID-19 Vaccine Dose Is Highly Effective in Patients With Cirrhosis

• Nanotechnology, Messenger RNA Combined in Possible New 'universal' COVID-19 Treatment

• Myocarditis Seven Times More Likely With COVID-19 Than Vaccines, Study Finds

• Time of Day Might Not Matter for COVID-19 Vaccination

• Scientists Shed Light on COVID-19 Booster Dose Effectiveness Among the Elderly in Japan

• Mouthwashes May Suppress SARS-CoV-2, Study Finds
• COVID-19: Boosting With an mRNA Vaccine Offers Better Protection in People Who Received Two Doses of CoronaVac

• New Findings on the Effects of COVID-19 on the Colon

• SARS-CoV-2 Mimics Could Accelerate Vaccine Research, Make It Safer

• Mucosal Antibodies in the Airways Protect Against Omicron Infection

• SARS-CoV-2 Immunity Research: Study Suggests Breakthrough Infection May Confer Extra Protection to Vaccinees

• Three COVID-19 Vaccines May Provide Greater Protection from COVID-19 Infections Than Two, Study Suggests

• Risk of Children Orphaned from COVID-19 Highest in Poorest Countries

• SARS-CoV-2 Antigen Levels Linked to Patient Outcomes

• Most People Infected With Omicron Didn't Know It, Study Finds
• Gene Inhibitor Could Help Slow Thrombosis in COVID-19 Patients

• Universal Vaccine Needed to Prevent Future COVID-19 Waves, Study Suggests
• Increase in Non-COVID-19 Respiratory Infections Predicted This Winter

• The Lining of Children's Noses May Provide Protection from SARS-CoV-2 Infection
• Variant Type and Patient Sex Affect Molnupiravir Efficacy, Study Finds

• New Needle-Free Nasal Vaccine Shows Promise for COVID-19
• COVID Vaccine Patch Fights Variants Better Than Needles, Study in Mice Shows

• Promising Developments in Pursuit to Design Pan-Coronavirus Vaccine

• SARS-CoV-2 Variants Have Developed Resistance to Human Interferons, Study Finds
• Coronavirus Spike Protein Activated Natural Immune Response, Damaged Heart Muscle Cells, Study Finds
• A Third COVID-19 Booster Is Crucial to Identifying and Fighting New Variants, Study Finds

• COVID-19 Vaccine Does Not Negatively Affect Placental Health, Study Finds

• Your Body Remembers Common Cold Coronaviruses from Childhood. How Can You Get the Same Immunity to COVID-19?
• Protective T Cells Remain 20 Months After COVID-19, Study Finds
• Hypertension Elevates Risk for More Severe COVID-19 Illness

• Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time
• COVID-19 Transmission in Geriatric Acute Care Shows Need for Enhanced Infection Control and Prevention Measures
• Booster Shots Offset Some of Omicron Immune Evasion Tactics
• New Key Protection Against COVID-19 Found in Saliva

• Scientists Identify What Makes the Delta Variant Dangerous and Explain the Recent Surge in COVID-19 Infections
• Second mRNA Booster Significantly Effective Against Omicron Variants, Study Finds

• Vaccine Protection Against COVID-19 Short-Lived, Booster Shots Important, New Study Says

• Coinfection With Influenza A Could Suppress Replication in SARS-CoV-2, Study Shows

• How Omicron Dodges the Immune System

• Inhalable COVID-19 Vaccine Shows Promise in Rodent Model
• Dominant Omicron Subvariants Better at Evading Vaccines, Antibody Treatments

• New Antibody Detection Method for Coronavirus That Does Not Require a Blood Sample

• Which COVID-19 Vaccine Type and Timing Are Best During Pregnancy?

• COVID-19 Omicron Variant Leads to Less Severe Disease in Mice, Study Finds
• The Surprising Link Between SARS-CoV-2 Infection and New-Onset Diabetes

• Long COVID Risk Less During Omicron Compared to Delta, Study Finds

• Qatar Omicron-Wave Study Shows Slow Decline of Natural Immunity, Rapid Decline of Vaccine Immunity

• Novel Host Cell Pathway Hijacked During COVID-19 Infection Uncovered

• Biotechnology Platforms Enable Fast, Customizable Vaccine Production

• COVID-19 Vaccination During Pregnancy Could Protect Against SARS-CoV-2 Infection in Infants

• COVID-19 Patient Antibodies Point Researchers Toward Broad Coronavirus Vaccines
• End of Strict COVID Measures in China Could Result in 1.5 Million Deaths, Study Finds

• New Study Points to Potential Strategy to Reduce Fatigue After COVID-19 Vaccination

• Population-Scale Study Highlights Ongoing Risk of COVID-19 in Some Cancer Patients Despite Vaccination

• Repurposed Antibiotic May Be an Effective Therapeutic in COVID-19 Infected Mice

• COVID Booster Needed for Broad Protection Against Omicron Variants

• mRNA Vaccines Like Pfizer and Moderna Fare Better Against COVID-19 Variants of Concern

• Scientists Explain What Makes COVID-19 Antibody 'J08' So Potent

• Investigational COVID Mucosal Vaccine Protects Against Disease and Transmission
• How a COVID-19 Infection Spurs Antibodies Against Common Colds

• Omicron Prompted Spike in COVID Cases in Pregnant Women, but Fewer Hospitalizations

• Scientists Develop COVID-19 Antibody Measurement Technology to Rapidly Assess Virus Blocking Efficacy

• COVID-19 Vaccine Protects Kids and Teens from Severe Illness

• COVID-19:疫苗接种大大减少传染性Viral Load, Study Finds

• Omicron: Number of Vaccine Breakthroughs in Cancer Patients on the Rise, Study Finds

• Study Details Critical Role of Viral Gene ORF8 in COVID-19 Infection and Outcomes

• Newly Developed COVID Vaccine from Austria Could Protect Against Omicron and Other Variants, Study Finds

• Omicron 'less Severe' Than Delta for Children Ages 4 and Younger, Study Suggests

• Common Coronavirus Infections Don't Generate Effective Antibodies Against SARS-CoV-2, Study Finds

• Prior COVID-19 Infection Linked to Robust, Accelerated Immune Response After First Vaccine Dose, Researchers Report
• Lung Damage May Persist Long After COVID-19 Pneumonia

• COVID-19 Mixed With Flu Increases Risk of Severe Illness and Death

• Children's Antibody Responses to COVID-19 Are Stronger Than Adults', Study Finds

• COVID-19 Increases Risk of Type 2 Diabetes, Study Finds

• Delta Breakthrough Infection Generates Broad Neutralizing Antibody Response in Double Vaccinated Individuals
• Mother to Child Transmission of COVID-19 Infection, Possible but Rare, Study Finds

• Antivirals, Some Antibodies, Work Well Against BA.2 Omicron Variant of COVID-19 Virus

• Vaccine and Antibody Treatment Effectiveness Blunted by All Three Omicron Subvariants

• Mucus Could Explain Why SARS-CoV-2 Doesn't Spread Easily from Surfaces

• Booster Critical as COVID-19 Vaccine-Induced Antibodies Wane in 6 Months, Don't Protect Against Omicron, Researchers Find

• Bark of Neem Tree May Protect Against Coronavirus Variants, Study Finds

• A Potential Antiviral for SARS and SARS-Like Coronaviruses

• Review of Pre-Omicron Data Finds COVID-19 Vaccine Protection from Severe Disease Remains Strong at Six Months

• SARS-CoV-2 Protein Targeted by Immune Cells Also Triggers Response in Bat Coronaviruses, Study Shows
• Increased Infectivity, Antibody Escape Drive SARS-CoV-2 Evolution, Studies Say